Table 3 Baseline and intraoperative characteristics of patients
All patients | Mechanical valve | No mechanical valve | ||||
|---|---|---|---|---|---|---|
N = 411 | N = 257 | N = 154 | ||||
CIED procedure - no. (%) | ||||||
New implant | ||||||
Pacemaker | ||||||
Single or dual chamber | 131 | 31.9% | 81 | 31.5% | 50 | 32.5% |
Cardiac resynchronization therapy | 14 | 3.4% | 9 | 3.5% | 5 | 3.3% |
Implantable cardioverter-defibrillator | ||||||
Single or dual chamber | 21 | 5.1% | 6 | 2.3% | 15 | 9.7% |
Cardiac resynchronization therapy | 27 | 6.6% | 9 | 3.5% | 18 | 11.7% |
Device replacement or revision | ||||||
Pulse-generator change only | 191 | 46.5% | 129 | 50.2% | 6 | 40.3% |
Pulse-generator change with additional procedure | 27 | 6.6% | 23 | 9.0% | 4 | 2.6% |
INR on day of surgery - mean ± S.D. | 1.44 | ± 0.22 | 1.44 | ± 0.21 | 1.43 | ± 0.24 |
Warfarin resumption after surgery -days | ||||||
Mean ± S.D. | 0.46 | ± 1.01 | 0.23 | ± 0.51 | 0.84 | ± 1.45 |
Median, IQR | 0 | 0–1 | 0 | 0–0 | 0 | 0–1 |
Anti-coagulation interruption period - days | ||||||
Mean ± S.D. | 4.04 | ± 2.04 | 3.91 | ± 1.71 | 4.27 | ± 2.47 |
Median (IQR) | 3 | 3–5 | 3 | 3–5 | 4 | 3–5 |